Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by TAKEDA PHARMS USA

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
020406 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021073 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
021428 New Drug Application Approval New formulation (S) Standard review drug
021782 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021842 New Drug Application Approval New combination (S) Standard review drug
021856 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021925 New Drug Application Approval New combination (S) Standard review drug
022024 New Drug Application Approval New formulation (S) Standard review drug
022271 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
022287 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
022352 New Drug Application Approval Drug already marketed, but without an approved NDA (P) Priority review drug
022426 New Drug Application Approval New combination (S) Standard review drug
050757 New Drug Application Approval New combination (S) Standard review drug
125476 Biologic License Application Approval
202799 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
203414 New Drug Application Approval New combination (S) Standard review drug
204447 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
208056 New Drug Application Approval New formulation (S) Standard review drug

Back to Companies who have applied for FDA Drug Approval